Trisubstituted chiral lactam derivative and preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- INST OF PHARMACOLOGY & TOXICOLOGY ACAD OF MILITARY MEDICAL SCI P L A
- Publication Date
- 2010-06-23
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to novel trisubstituted chiral γ-lactam derivatives capable of antagonizing human chemokine receptor 4 (abbreviated as hCCR4), the preparation method of these compounds, the pharmaceutical composition containing the above compounds, and the use of the compounds Use in the preparation of medicines for treating and / or preventing hCCR4-mediated diseases or conditions. technical background
[0002] CCR4 (Chemokine Receptor 4, Chemokine Receptor 4) was first discovered by Christine A.Power et al. in 1995 (Christine AP et al. J.Biol.Chem.1995, 270(8):19495-19500), which belongs to chemotaxis One of the members of the factor receptor (CCR) family, it is a 7-transmembrane G-protein coupled receptor. It has two naturally occurring specific ligands: MDC (Macrophage-derived chemokine) and TARC (thymus and activation regulated chemokine) (Sadatoshi Maeda et al. Veterinary Immunology and Immunopathology 2002(90): 145-154). The newly ...